STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,382,674
-58.1%
62,636
+0.2%
0.01%
-53.8%
Q2 2023$5,692,475
+206.9%
62,486
+122.2%
0.01%
+225.0%
Q1 2023$1,854,531
+27.6%
28,1160.0%0.00%0.0%
Q4 2022$1,453,878
-23.9%
28,116
+0.5%
0.00%
-20.0%
Q3 2022$1,910,000
+51.0%
27,9660.0%0.01%
+66.7%
Q2 2022$1,265,000
-7.1%
27,966
+4.4%
0.00%0.0%
Q1 2022$1,362,000
+7.5%
26,7960.0%0.00%
+50.0%
Q4 2021$1,267,000
+43.5%
26,7960.0%0.00%0.0%
Q3 2021$883,000
-47.9%
26,7960.0%0.00%
-33.3%
Q2 2021$1,694,000
+65.3%
26,796
+12.1%
0.00%
+50.0%
Q1 2021$1,025,000
-26.0%
23,895
-1.3%
0.00%
-33.3%
Q4 2020$1,385,000
+84.2%
24,215
-2.8%
0.00%
+50.0%
Q3 2020$752,000
+1.5%
24,915
+9.8%
0.00%0.0%
Q2 2020$741,000
+35.2%
22,695
+11.0%
0.00%0.0%
Q1 2020$548,000
+3.2%
20,447
+17.9%
0.00%
+100.0%
Q4 2019$531,000
+28.3%
17,347
+0.9%
0.00%0.0%
Q3 2019$414,000
-5.0%
17,1870.0%0.00%0.0%
Q2 2019$436,000
+79.4%
17,187
+37.9%
0.00%0.0%
Q1 2019$243,000
+48.2%
12,4670.0%0.00%
Q4 2018$164,000
-14.6%
12,467
+15.3%
0.00%
Q3 2018$192,00010,8080.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders